newsfilter
← Latest News
PR Newswire·

TC BioPharm to Present at Upcoming Investor Conferences

EDINBURGH, Scotland, Oct. 3, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP) (NASDAQ:TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, tod